These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 16764778)
21. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer. Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128 [TBL] [Abstract][Full Text] [Related]
22. [Insulin-like growth factor (IGF-1) and the clinical course of prostate cancer, benign hyperplasia and prostatic intraepithelial neoplasia]. Povelitsa EA; Nabyrov EA Vopr Onkol; 2008; 54(5):596-601. PubMed ID: 19069473 [TBL] [Abstract][Full Text] [Related]
23. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade. Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272 [TBL] [Abstract][Full Text] [Related]
24. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma]. Li H; Zhang N Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429 [TBL] [Abstract][Full Text] [Related]
25. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma. Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056 [TBL] [Abstract][Full Text] [Related]
26. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR. Xu W; Fan H; He X; Zhang J; Xie W J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846 [TBL] [Abstract][Full Text] [Related]
27. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer. Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198 [TBL] [Abstract][Full Text] [Related]
28. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer. Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Schwartz P; Yu H Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738 [TBL] [Abstract][Full Text] [Related]
29. [Characteristics of IGF-II gene imprinting in twin placentas]. Luo YM; Fang Q; Zhuang GL; Liang RC; Liu QL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):497-501. PubMed ID: 17029194 [TBL] [Abstract][Full Text] [Related]
30. [Relationship between insulin-like growth factor II and prognosis of colorectal cancer]. Xu Z; Liu F; Qi X; Li J Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):718-20, 43. PubMed ID: 11829934 [TBL] [Abstract][Full Text] [Related]
31. Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection. Maenaka S; Hikichi T; Imai MA; Minamoto T; Kawahara E Oncol Rep; 2006 Apr; 15(4):791-5. PubMed ID: 16525660 [TBL] [Abstract][Full Text] [Related]
32. Interrelationships between dietary restriction, the IGF-I axis, and expression of vascular endothelial growth factor by prostate adenocarcinoma in rats. Powolny AA; Wang S; Carlton PS; Hoot DR; Clinton SK Mol Carcinog; 2008 Jun; 47(6):458-65. PubMed ID: 18058807 [TBL] [Abstract][Full Text] [Related]
33. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis. Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862 [TBL] [Abstract][Full Text] [Related]
34. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Cui H; Horon IL; Ohlsson R; Hamilton SR; Feinberg AP Nat Med; 1998 Nov; 4(11):1276-80. PubMed ID: 9809551 [TBL] [Abstract][Full Text] [Related]
35. Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer. Tsuchiya N; Wang L; Suzuki H; Segawa T; Fukuda H; Narita S; Shimbo M; Kamoto T; Mitsumori K; Ichikawa T; Ogawa O; Nakamura A; Habuchi T J Clin Oncol; 2006 May; 24(13):1982-9. PubMed ID: 16648498 [TBL] [Abstract][Full Text] [Related]
37. IGF-II in primary human colorectal tumors: peptide level, activated promoters, parental imprinting and gene rearrangement. Winkler R; Delacroix L; Bensbaho K; Lambert S; Collette J; Hodzic D Horm Metab Res; 1999; 31(2-3):148-54. PubMed ID: 10226796 [TBL] [Abstract][Full Text] [Related]
38. Genomic imprinting of IGF-II and H19 in adult human pancreatic tissues. Micha AE; Hähnel S; Friess H; Büchler MW; Adler G; Gress TM Digestion; 1999; 60(5):477-83. PubMed ID: 10473973 [TBL] [Abstract][Full Text] [Related]
39. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population. Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454 [TBL] [Abstract][Full Text] [Related]
40. ARE-I polymorphism on PSA gene in prostate cancer patients of a Turkish population. Kalay E; Ergen A; Narter F; Agaçhan B; Görmüs U; Yigit N; Isbir T Anticancer Res; 2009 Apr; 29(4):1395-8. PubMed ID: 19414393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]